Business Context and Reporting Period
This Form 8-K was filed by Biorestorative Therapies, Inc. on February 28, 2020, reporting events occurring between February 27, 2020, and February 28, 2020. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or liquidity ratios. The primary financial data disclosed relates to a specific capital transaction:
- Debt Converted: $98,953 (aggregate amount of outstanding indebtedness, inclusive of accrued and unpaid interest and imputed additional principal).
- Shares Issued: 98,952,799 shares of common stock.
- Total Outstanding Shares: Approximately 1,793,503,850 shares following the issuance.
- Authorized Shares: 2,000,000,000 shares.
Material Changes
The material change reported is the unregistered sale of equity securities. The Company issued approximately 99 million shares of common stock upon the exercise of conversion rights by holders of convertible promissory notes. This transaction converted a nominal amount of debt ($98,953) into a significant number of equity shares, resulting in a substantial increase in the total shares issued and outstanding.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the transaction. The Company relied on exemptions under Section 4(a)(2) and Section 3(a)(9) of the Securities Act of 1933, asserting that the securities were offered to a limited number of persons who are reasonably believed to be accredited investors. No general solicitation or advertising was used.
Investor Verification Checklist
- Verify the conversion price implied by the issuance of ~99 million shares for ~$99,000 of debt.
- Confirm the dilution impact on existing shareholders given the increase to ~1.79 billion outstanding shares.
- Review the terms of the convertible promissory notes to understand the accrued interest and imputed principal calculations.
- Check subsequent filings for any updates on the company's liquidity position following this capitalization event.